On 29th September 2022, we brought together market access professionals from across Pharma and Medtech for our NHS Engagement Symposium: ‘People, pathways and payments – Mastering the key pillars of…
Read More
In the field of systematic reviews and evidence synthesis, strong, multi-partner teams are critical for moving new drugs from early development and testing in the lab to treating people in…
Inspired by the oral presentations and panel discussions at the recent HTAi Conference in Utrecht, The Netherlands, Persefoni Ioannou (Consultant – Health Technology Assessment [HTA]) shares some key trends in...
Read More
Tom Clarke (Director, NHS Insight & Interaction) explores what new integrated care legislation means for UK market access and for industry engagement with NHS decision-makers across England. July 1st saw...
Read More
How will the legislation of Integrated Care Systems in July 2022, and the ‘New NHS’ impact on Pharma market access? NHS England is going through its most significant changes for...
Read More
People, pathways, and payments – Mastering the key pillars of NHS engagement in 2023 Pharma and Medtech market access professionals joined us and our guest speakers from across the NHS...
Read More
Specialised services have long been the subject of debate around their place in Integrated Care Systems (ICSs), who will run them and how will they be funded. On 31st May...
Read More
We sit down with Emily Mair to learn more about her work as an Associate Consultant and how her career has developed, following earlier commercial roles. She shares her highlights...
Read More
On 13th April NHS England published the initial 2022/23 budgets of the 42 Integrated Care Boards (ICBs) expected to go live from 1st July 2022, subject to legislative approval. The...
Read More
NHS England published its 2022/23 National Tariff Payment System on 31st March 2022, a day before the new NHS financial year. The system provides guidance for the continued running of...
Read More
